专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20180008581A1 ANTIFIBROTIC COMPOUNDS AND USES THEREOF 审中-公开
公开(公告)号：US20180008581A1
公开(公告)日：2018-01-11
申请号：US15462859
申请日：2017-03-19
申请人： Bijoy PANICKER , Rama K. MISHRA , Dong Sung LIM , Lambertus J.W.M. OEHLEN , Dawoon JUNG
发明人： Bijoy PANICKER , Rama K. MISHRA , Dong Sung LIM , Lambertus J.W.M. OEHLEN , Dawoon JUNG
IPC分类号： A61K31/437 , A61K31/5377 , A61K31/496
CPC分类号： A61K31/4353 , A61K31/437 , A61K31/496 , A61K31/5377 , C07D401/02 , C07D401/14 , C07D471/04
摘要： The present invention provides compounds having the general structural formula (I) and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving abnormal or excessive fibrosis.

2. 发明申请

US20150158853A1 CYTOCHROME P450 INHIBITORS AND USES THEREOF 审中-公开
标题翻译：细胞色素P450抑制剂及其用途
公开(公告)号：US20150158853A1
公开(公告)日：2015-06-11
申请号：US14493976
申请日：2014-09-23
申请人： Bijoy Panicker , Dong Sung Lim , Rama K. Mishra , Lambertus J.W.M. Oehlen , James G. Tarrant , Xiaokang Zhu , Dawoon Jung
发明人： Bijoy Panicker , Dong Sung Lim , Rama K. Mishra , Lambertus J.W.M. Oehlen , James G. Tarrant , Xiaokang Zhu , Dawoon Jung
IPC分类号： C07D417/06 , C07D417/14
CPC分类号： C07D417/06 , C07D417/04 , C07D417/12 , C07D417/14
摘要： The present invention provides compounds having the general structural formula (I) and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving fibrosis and proliferation, and where anti-fibrotic or anti-proliferative activity is beneficial.
摘要翻译：本发明提供具有一般结构式（I）的化合物及其药学上可接受的衍生物，如本文中一般和本类和亚类所述，并且另外提供其药物组合物，以及用于治疗任何一种涉及纤维化和增殖的病症或疾病，其中抗纤维化或抗增殖活性是有益的。

3. 发明授权

US08735405B2 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors 有权
标题翻译： 6,6-双环取代杂双环蛋白激酶抑制剂
公开(公告)号：US08735405B2
公开(公告)日：2014-05-27
申请号：US13446629
申请日：2012-04-13
申请人： Lee D. Arnold , Cara Cesario , Heather Coate , Andrew P. Crew , Hanqing Dong , Kenneth Foreman , Ayako Honda , Radoslaw Laufer , An-Hu Li , Kristen Michelle Mulvihill , Mark J. Mulvihill , Anthony I. Nigro , Bijoy Panicker , Arno G. Steinig , Yingchuan Sun , Quinghua Weng , Douglas S. Werner , Michael J. Wyle , Tao Zhang
发明人： Lee D. Arnold , Cara Cesario , Heather Coate , Andrew P. Crew , Hanqing Dong , Kenneth Foreman , Ayako Honda , Radoslaw Laufer , An-Hu Li , Kristen Michelle Mulvihill , Mark J. Mulvihill , Anthony I. Nigro , Bijoy Panicker , Arno G. Steinig , Yingchuan Sun , Quinghua Weng , Douglas S. Werner , Michael J. Wyle , Tao Zhang
IPC分类号： A01N43/90 , A61K31/519 , C07D487/00
CPC分类号： C07F5/025 , C07D471/04 , C07D487/04
摘要： Compounds of the formula and pharmaceutically acceptable salts thereof, wherein X1, X2, X3, X4, X5, X6, X7, R1, and Q1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.
摘要翻译：其中X 1，X 2，X 3，X 4，X 5，X 6，X 7，R 1和Q 1在本文中定义的式及其药学上可接受的盐的化合物抑制IGF-1R酶，并且可用于治疗和/或预防过度增生性疾病如癌症，炎症，牛皮癣，过敏/哮喘，免疫系统的疾病和状况，中枢神经系统的疾病和状况。

4. 发明申请

US20130102643A1 CYTOCHROME P450 INHIBITORS AND USES THEREOF 有权
公开(公告)号：US20130102643A1
公开(公告)日：2013-04-25
申请号：US13700730
申请日：2011-06-01
申请人： Bijoy Panicker , Lambertus J.W.M. Oehlen , James G. Tarrant , Dong Sung Lim , Xiaokang Zhu , Dawoon Jung , Rama K. Mishra
发明人： Bijoy Panicker , Lambertus J.W.M. Oehlen , James G. Tarrant , Dong Sung Lim , Xiaokang Zhu , Dawoon Jung , Rama K. Mishra
IPC分类号： C07D417/06
CPC分类号： C07D417/06 , C07D417/04 , C07D417/12 , C07D417/14
摘要： The present invention provides compounds having the general structural formula (I) and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving fibrosis and proliferation, and where anti-fibrotic or anti-proliferative activity is beneficial.

5. 发明申请

US20120077979A1 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors 失效
标题翻译： 6,6-双环取代杂双环蛋白激酶抑制剂
公开(公告)号：US20120077979A1
公开(公告)日：2012-03-29
申请号：US13308694
申请日：2011-12-01
申请人： Lee D. Arnold , Heather Coate , Andrew Philip Crew , Hanqing Dong , Kenneth Foreman , Ayako Honda , Radoslaw Laufer , An-Hu Li , Kristen Michelle Mulvihill , Mark Joseph Mulvihill , Anthony Nigro , Bijoy Panicker , Arno G. Steinig , Qingua Weng , Douglas S. Werner , Michael J. Wyle , Tao Zhang , Cara Cesario , Yingchuan Sun
发明人： Lee D. Arnold , Heather Coate , Andrew Philip Crew , Hanqing Dong , Kenneth Foreman , Ayako Honda , Radoslaw Laufer , An-Hu Li , Kristen Michelle Mulvihill , Mark Joseph Mulvihill , Anthony Nigro , Bijoy Panicker , Arno G. Steinig , Qingua Weng , Douglas S. Werner , Michael J. Wyle , Tao Zhang , Cara Cesario , Yingchuan Sun
IPC分类号： C07D487/04 , C07F5/02
CPC分类号： C07F5/025 , C07D471/04 , C07D487/04
摘要： Compounds of the formula and pharmaceutically acceptable salts thereof, wherein X1, X2, X3, X4, X5, X6, X7, R1, and Q1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.
摘要翻译：其中X 1，X 2，X 3，X 4，X 5，X 6，X 7，R 1和Q 1在本文中定义的式及其药学上可接受的盐的化合物抑制IGF-1R酶，并且可用于治疗和/或预防过度增生性疾病如癌症，炎症，牛皮癣，过敏/哮喘，免疫系统的疾病和状况，中枢神经系统的疾病和状况。

6. 发明授权

US07820662B2 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors 有权
标题翻译： 6,6-双环取代杂双环蛋白激酶抑制剂
公开(公告)号：US07820662B2
公开(公告)日：2010-10-26
申请号：US12244947
申请日：2008-10-03
申请人： Lee D. Arnold , Cara Cesario , Heather Coate , Andrew Philip Crew , Hanqing Dong , Kenneth Foreman , Ayako Honda , Radoslaw Laufer , An-Hu Li , Kristen Michelle Mulvihill , Mark J. Mulvihill , Anthony I. Nigro , Bijoy Panicker , Arno G. Steinig , Yingchuan Sun , Quinghua Weng , Douglas S. Werner , Michael J. Wyle , Tao Zhang
发明人： Lee D. Arnold , Cara Cesario , Heather Coate , Andrew Philip Crew , Hanqing Dong , Kenneth Foreman , Ayako Honda , Radoslaw Laufer , An-Hu Li , Kristen Michelle Mulvihill , Mark J. Mulvihill , Anthony I. Nigro , Bijoy Panicker , Arno G. Steinig , Yingchuan Sun , Quinghua Weng , Douglas S. Werner , Michael J. Wyle , Tao Zhang
IPC分类号： C07D487/00 , A01N43/64
CPC分类号： C07F5/025 , C07D471/04 , C07D487/04
摘要： Compounds of the formula and pharmaceutically acceptable salts thereof, wherein X1, X2, X3, X4, X5, X6, X7, R1, and Q1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.
摘要翻译：其中X 1，X 2，X 3，X 4，X 5，X 6，X 7，R 1和Q 1在本文中定义的式及其药学上可接受的盐的化合物抑制IGF-1R酶，并且可用于治疗和/或预防过度增生性疾病如癌症，炎症，牛皮癣，过敏/哮喘，免疫系统的疾病和状况，中枢神经系统的疾病和状况。

7. 发明授权

US07700594B2 Fused bicyclic mTOR inhibitors 有权
标题翻译：融合双环mTOR抑制剂
公开(公告)号：US07700594B2
公开(公告)日：2010-04-20
申请号：US11599663
申请日：2006-11-15
申请人： Xin Chen , Heather Coate , Andrew Philip Crew , Han-Qing Dong , Ayako Honda , Mark Joseph Mulvihill , Paula A. R. Tavares , Jing Wang , Douglas S. Werner , Kristen Michelle Mulvihill , Kam W. Siu , Bijoy Panicker , Apoorba Bharadwaj , Lee D. Arnold , Meizhong Jin , Brian Volk , Qinghua Weng , James David Beard
发明人： Xin Chen , Heather Coate , Andrew Philip Crew , Han-Qing Dong , Ayako Honda , Mark Joseph Mulvihill , Paula A. R. Tavares , Jing Wang , Douglas S. Werner , Kristen Michelle Mulvihill , Kam W. Siu , Bijoy Panicker , Apoorba Bharadwaj , Lee D. Arnold , Meizhong Jin , Brian Volk , Qinghua Weng , James David Beard
IPC分类号： C07D487/04 , C07D401/14 , C07D403/04 , A61K31/53 , A61K31/4523 , A61K35/00
CPC分类号： C07D487/04 , A61K31/5025 , C07D253/07 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/14
摘要： Compounds represented by Formula (I) or a pharmaceutically acceptable salt thereof, are inhibitors of mTOR and useful in the treatment of cancer.
摘要翻译：由式（I）表示的化合物或其药学上可接受的盐是mTOR的抑制剂，可用于治疗癌症。

8. 发明授权

US07618965B2 (Arylamidoanilino)nitroethylene compounds 失效
标题翻译：（芳基酰氨基苯胺基）硝基乙烯化合物
公开(公告)号：US07618965B2
公开(公告)日：2009-11-17
申请号：US11227697
申请日：2005-09-15
申请人： Andrew Crew , An-Hu Li , Bijoy Panicker
发明人： Andrew Crew , An-Hu Li , Bijoy Panicker
IPC分类号： A61K31/535 , A61K31/47 , C07D413/00 , C07D215/00 , C07D215/02
CPC分类号： C07D409/12 , C07D409/14
摘要： Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, wherein A, Q, Y, R1, R2, and R5 are defined herein, are useful in the treatment of tumors and cancers such as mastocytosis/mast cell leukemia, gastrointestinal stromal tumors (GIST), germ cell tumors, small cell lung carcinoma (SCLC), sinonasal natural killer/T-cell lymphoma, testicular cancer (seminoma), thyroid carcinoma, malignant melanoma, ovarian carcinoma, adenoid cystic carcinoma, acute myelogenous leukemia (AML), breast carcinoma, pediatric T-cell acute lymphoblastic leukemia, neuroblastoma, mast cell leukemia, angiosarcoma, anaplastic large cell lymphoma, endometrial carcinoma, and prostate carcinoma.
摘要翻译：式（I）表示的化合物或其药学上可接受的盐或N-氧化物，其中A，Q，Y，R 1，R 2和R 5在本文中定义，可用于治疗肿瘤和癌症，例如肥大细胞增多症/桅杆细胞白血病，胃肠道间质瘤（GIST），生殖细胞肿瘤，小细胞肺癌（SCLC），鼻窦自然杀伤/ T细胞淋巴瘤，睾丸癌（精原细胞瘤），甲状腺癌，恶性黑素瘤，卵巢癌，腺样囊性癌，急性骨髓性白血病（AML），乳腺癌，儿科T细胞急性淋巴细胞白血病，成神经细胞瘤，肥大细胞白血病，血管肉瘤，间变性大细胞淋巴瘤，子宫内膜癌和前列腺癌。

9. 发明申请

US20090118499A1 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors 有权
公开(公告)号：US20090118499A1
公开(公告)日：2009-05-07
申请号：US12244947
申请日：2008-10-03
申请人： Lee D. Arnold , Heather Coate , Andrew Philip Crew , Hanqing Dong , Kenneth Foreman , Ayako Honda , Radoslaw Laufer , An-Hu Li , Kristen Michelle Mulvihill , Mark Joseph Mulvihill , Anthony Nigro , Bijoy Panicker , Arno G. Steinig , Quinghua Weng , Douglas S. Werner , Michael J. Wyle , Tao Zhang , Cara Cesario , Yingchuan Sun
发明人： Lee D. Arnold , Heather Coate , Andrew Philip Crew , Hanqing Dong , Kenneth Foreman , Ayako Honda , Radoslaw Laufer , An-Hu Li , Kristen Michelle Mulvihill , Mark Joseph Mulvihill , Anthony Nigro , Bijoy Panicker , Arno G. Steinig , Quinghua Weng , Douglas S. Werner , Michael J. Wyle , Tao Zhang , Cara Cesario , Yingchuan Sun
IPC分类号： C07D487/04
CPC分类号： C07F5/025 , C07D471/04 , C07D487/04
摘要： Compounds of the formula and pharmaceutically acceptable salts thereof, wherein X1, X2, X3, X4, X5, X6, X7, R1, and Q1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.

10. 发明授权

US08772326B2 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity 有权
标题翻译：肝细胞生长因子（分散因子）活性的小分子调节剂的方法和组成
公开(公告)号：US08772326B2
公开(公告)日：2014-07-08
申请号：US13003514
申请日：2009-07-09
申请人： Weizhong Cai , Prakash Narayan , Bijoy Panicker , David E. Smith
发明人： Weizhong Cai , Prakash Narayan , Bijoy Panicker , David E. Smith
IPC分类号： A01N43/56 , A61K31/415 , A01N43/00 , A61K31/55 , A01N57/00 , A61K31/675 , C07D231/00
CPC分类号： C07D409/14 , A61K9/0019 , A61K9/145 , A61K9/146 , A61K9/1652 , A61K9/19 , A61K9/4866 , A61K31/415 , A61K31/4155 , C07D231/12 , C07D405/06 , C07D405/14 , C07D409/06
摘要： The present invention provides compositions and formulations of compounds having formula (I) and pharmaceutically acceptable derivatives thereof, wherein p, R1, R2 and B are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of injuries, conditions or diseases in which HGF/SF or the activities thereof, or agonists or antagonists thereof have a therapeutically useful role. In addition, methods are provided for treating such diseases or diseases starting at a time after the onset of the injury, condition or disease.
摘要翻译：本发明提供具有式（I）的化合物及其药学上可接受的衍生物的组合物和制剂，其中p，R 1，R 2和B如本文中一般和本领域和亚类所述，并且另外提供其药物组合物，以及用于其用于治疗HGF / SF或其活性或其激动剂或拮抗剂具有治疗有用作用的许多损伤，病症或疾病中的任何一种。此外，提供了用于治疗在损伤，病症或疾病发作后的时间开始的这些疾病或疾病的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式